Collateral Medical Pvt Ltd. is a leading medical device marketing, distribution, and retailing company that uses direct marketing to reach customers across India – including Tier 2 and 3 cities and towns.

ColMed’s e-commerce portal www.colmed.in is popular among healthcare professionals, small hospitals and patients for sourcing medical devices. The company has always focused on the use of technology to address the reach/access of medical devices to the end users in every corner of the country.

The company has tied up with various manufacturers of medical devices from countries like the USA, the UK, China, Korea to market and sell their products in India. We also have distribution and retail tie-ups with established players in India such as Abbott, BD, Cochlear, Convatec, J&J, 3M, GE, Roche etc to enable better visibility and efficient distribution of medical devices across India.

Apart from sales and marketing Collateral Medical also offers pan-India after-sales service support and a strong customer feedback management system for logging, reporting, and tracking complaints. The Operations and Sales & Marketing team includes Biomedical Engineers from leading universities and this ensures that our communication with the healthcare workers is the best in Industry.

The Leadership Team of Collateral Medical comprises people with educational qualifications from IITs, London Business School, and INSEAD who have strong leadership experience from medical device companies like Johnson & Johnson Medical, SRL, GE Healthcare; Supply Chain experts from leading hospital chains and medical device logistics companies in India. The board of Collateral Medical constitutes industry leaders from Healthcare and Financial world.

The company focuses on the use of technology and innovation to bring efficiency in access of Medtech and believes that partnerships are a key enabler to achieve this end. ColMed’s customers include tens of thousands of healthcare professionals, hundreds of thousands of customers, thousands of retailers, over one thousand wholesalers, and 20 of the top 20 pharmaceutical companies.

The company was founded in 2010, is well funded through VC/PE funding, and has partnerships with leading healthcare care and impact-focused debt funds. The company believes in proven economic business models and strong unit economics for value creation for all stakeholders